semaglutide a1c reduction in HbA1c with oral and comparators. A, Primary CagriSema demonstrated superior HbA1c reduction

12:301:30 pm CDT Semaglutide 7.2 mg 1966-LB Efficacy and Safety of Semaglutide 7.2 mg in ObesitySTEP UP Trial Saturday, June 21

Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists

Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG, Antonoff MB

During this period, patients often lose 2-5% of body weight rapidly, which can temporarily deplete energy reserves